Shariah compliance overview
Not HalalAvalyn Pharma Inc. Common Stock (AVLN) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Avalyn Pharma Inc. Common Stock
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs).
Avalyn Pharma Inc. Common Stock (AVLN) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 0.00%Limit 30%Pass
- Interest-bearing securities and assets
- 10.28%Limit 30%Pass
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Avalyn Pharma Inc. Common Stock (AVLN). Current Akinda screening label: Not Halal.
